Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BostonView who wrote (431)	12/2/1999 7:38:00 PM
From: Biomaven	Read Replies (2) of 3044

I too have a low cost basis, averaging around $17. I first bought in 1997 at around $20, then added in 1998 at levels down to $15. I'm holding firmly. My view is that while in the short/medium term the stock may possibly be ahead of itself, and would be vulnerable if there is a biotech correction, in the long term this stock has a good chance to be one of the crown jewels of biotech. They certainly are one of the most ambitious of the biotechs, and their execution to date has been flawless. Both their science and their management is widely perceived as being as good as anything in biotechland. In the very short term, anything to do with genomics is red hot, and MLNM is as good a place to be as any to take advantage of this current craze. Hadn't followed the RS MLNM ratings. Who's their MLNM analyst - Mike King? My guess is that at very worst they'll give it an enthusiastic long term rec and a cautious short term one because of the price appreciation. (Kind of like what they did for CELG last week when initiating coverage). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next